Development And Validation of RP-HPLC Method for The Simultaneous Determination of Olanzapine and Fluoxetine Hydrochloride in Bulk and Pharmaceutical Dosage Forms

Read full text Summarise with VIRAT
Authors: N. Pravalika*, Dr. Mohammed Ibrahim, Rehmath Unnisa
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

A simple, sensitive and precise reverse phase high performance liquid chromatographic method has been developed for the simultaneous estimation of olanzapine and fluoxetine hydrochloride in bulk and pharmaceutical dosage forms. The mobile phase consisted of potassium dihydrogen phosphate buffer adjusted to pH 3.0 with orthophosphoric acid:Acetonitrile in the ratio of 40:60v/v delivered at a flow rate of 1ml/min and wavelength of UV detection at 235nm.The retention times of fluoxetine hyrochloride and olanzapine were found to be 1.967 min and 5.740 min respectively. The linearity was observed and they were in the range of 10-50µg/ml and 5-25µg/ml for fluoxetine hydrochloride and olanzapine respectively. The developed method was validated according to ICH guidelines

Fields of Study & Subjects

Analytical Methods in Pharmaceuticals Forensic Toxicology and Drug Analysis Analytical Chemistry and Chromatography

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
20 March 2026
Language
EN